MX2017007196A - Fibroblastos de embrion de pollo inmortalizados. - Google Patents

Fibroblastos de embrion de pollo inmortalizados.

Info

Publication number
MX2017007196A
MX2017007196A MX2017007196A MX2017007196A MX2017007196A MX 2017007196 A MX2017007196 A MX 2017007196A MX 2017007196 A MX2017007196 A MX 2017007196A MX 2017007196 A MX2017007196 A MX 2017007196A MX 2017007196 A MX2017007196 A MX 2017007196A
Authority
MX
Mexico
Prior art keywords
chicken embryo
embryo fibroblasts
immortalised
cells
immortalised chicken
Prior art date
Application number
MX2017007196A
Other languages
English (en)
Inventor
Jaap Kool
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of MX2017007196A publication Critical patent/MX2017007196A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • C12N7/08—Inactivation or attenuation by serial passage of virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/02—Recovery or purification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/02—Recovery or purification
    • C12N7/025—Packaging cell lines, e.g. transcomplementing cell lines, for production of virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2330/00—Production
    • C12N2330/50—Biochemical production, i.e. in a transformed host cell
    • C12N2330/51—Specially adapted vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/04—Immortalised cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16351—Methods of production or purification of viral material

Abstract

La presente invención se relaciona con fibroblastos de embrión de pollo inmortalizados, con cultivos celulares que comprenden tales células inmortalizadas, con vacunas que comprenden tales células, con métodos para la propagación de virus aviares en tales células y con métodos para la preparación de tales células y tales vacunas.
MX2017007196A 2014-12-04 2015-12-03 Fibroblastos de embrion de pollo inmortalizados. MX2017007196A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14196345 2014-12-04
PCT/EP2015/078457 WO2016087560A1 (en) 2014-12-04 2015-12-03 Immortalised chicken embryo fibroblasts

Publications (1)

Publication Number Publication Date
MX2017007196A true MX2017007196A (es) 2017-08-28

Family

ID=52003640

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017007196A MX2017007196A (es) 2014-12-04 2015-12-03 Fibroblastos de embrion de pollo inmortalizados.

Country Status (10)

Country Link
US (1) US10428316B2 (es)
EP (1) EP3227433B1 (es)
JP (1) JP6546659B2 (es)
CN (1) CN107002044B (es)
BR (1) BR112017011582A2 (es)
ES (1) ES2700147T3 (es)
MX (1) MX2017007196A (es)
PL (1) PL3227433T3 (es)
RU (1) RU2694318C2 (es)
WO (1) WO2016087560A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR103245A1 (es) 2014-12-24 2017-04-26 Intervet Int Bv Vacuna vectorial basada en hvt (herpes virus de los pavos) frente a nd (enfermedad de newcastle) - ibd (enfermedad de gumboro) mejorada
WO2018093903A1 (en) * 2016-11-17 2018-05-24 Regents Of The University Of Minnesota Immortalized cell lines and methods of use
CN107099513B (zh) * 2017-06-22 2020-07-14 北京邦卓生物科技有限公司 一种共表达ndv hn和ibdv vp2基因的hvt的构建及其应用
US11479792B2 (en) * 2017-07-13 2022-10-25 Upside Foods, Inc. Compositions and methods for increasing the efficiency of cell cultures used for food production
US11291715B2 (en) 2017-12-20 2022-04-05 Intervet Inc. Diluent for cell-associated alphaherpesvirus vaccine
US20230031097A1 (en) 2019-12-20 2023-02-02 Intervet Inc. Multivalent hvt vector vaccine
US20210386854A1 (en) * 2020-06-15 2021-12-16 Zoetis Services Llc Cell Line for Production of Marek's Disease Virus Vaccine and Methods of Making and Using the Same
CA3190070A1 (en) 2020-09-07 2022-03-10 Martijn Alexander LANGEREIS Ha stem vaccine for ha antibody-positive targets
WO2022136623A1 (en) 2020-12-24 2022-06-30 Intervet International B.V. Multivalent hvt vector vaccine
CN112574946B (zh) * 2020-12-28 2023-12-12 中国科学院昆明动物研究所 一种原代分离培养土狗多个组织来源的成纤维细胞及其永生化的构建方法
WO2023285489A1 (en) 2021-07-13 2023-01-19 Intervet International B.V. Overcoming antibody-interference in avians
CN114107171B (zh) * 2021-11-12 2022-12-27 广东省华晟生物技术有限公司 鹅视网膜上皮细胞系及其构建方法与应用
CN114908053A (zh) * 2022-04-24 2022-08-16 上海交通大学 孔雀成纤维永生化细胞系的制备方法及其在病毒扩增中的应用
WO2023213946A1 (en) 2022-05-05 2023-11-09 Intervet International B.V. New multivalent hvt vector vaccine
CN114891722A (zh) * 2022-05-13 2022-08-12 广东省农业科学院动物卫生研究所 禽肠道上皮细胞及其制备方法和应用
CN114958769B (zh) * 2022-06-09 2024-03-12 浙江大学 一种永生化羊前体脂肪细胞系、及其制备方法和应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2749022B1 (fr) 1996-05-23 2001-06-01 Rhone Merieux Cellules aviaires immortelles
US5672485A (en) 1996-08-13 1997-09-30 Regents Of The University Of Minnesota Immortalized cell lines for virus growth
ATE373082T1 (de) * 2000-07-18 2007-09-15 Nestle Sa Pre-adipose zelllinien
EP1528101A1 (en) 2003-11-03 2005-05-04 ProBioGen AG Immortalized avian cell lines for virus production
CN100467596C (zh) * 2003-11-10 2009-03-11 日本可乐丽医疗器材株式会社 能可逆性增殖的表达胰岛素的人胰岛细胞株及其用途
WO2005100546A1 (ja) 2004-03-31 2005-10-27 Tokyo Metropolitan Organization For Medical Research 可逆性不死化哺乳類肝臓細胞およびその用途
ES2349483T3 (es) * 2006-01-05 2011-01-04 Transgene Sa Transcriptasa inversa de la telomerasa aviar.
RS51525B (en) * 2006-01-05 2011-06-30 Transgene Sa. Poultry telomeres reverse transcriptase
JP5016241B2 (ja) 2006-03-09 2012-09-05 中外製薬株式会社 不死化ヒトメサンギウム細胞
RU2475536C2 (ru) * 2007-07-03 2013-02-20 Трансген С.А. Иммортализованная клеточная линия птиц
EP2334693A4 (en) * 2008-07-18 2011-09-21 Chee Keong Choo METHODS OF LONG-TERM CULTURE OF EUKARYOTIC CELLS AND USES THEREOF
AU2010206374B2 (en) 2009-01-23 2013-01-17 Gloriana Therapeutics Sarl Improved cell lines and their use in encapsulated cell biodelivery
EP2248889A1 (en) * 2009-05-06 2010-11-10 Sanofi-Aventis Reversibly immortalized cells as well as methods relating hetero
BR112013031770A2 (pt) * 2011-06-10 2016-12-06 Univ Georgia população de células-tronco aviárias de pluripotência induzida, ave quimérica, método de reprogamação de uma célula embrionária aviária ou célula somática adulta, método de manipulação genética de espécies aviárias, método de instilar a resistência à doença em uma célula-tronco aviária pluripotente induzida, método de instilar a resistência à doença em uma população de célula-tronco aviária pluripotente, método para produzir um gameta de ave quimérica, método de produção de material imunogênico para uma vacina e vacina
CN102876717B (zh) * 2012-10-29 2014-06-11 东北农业大学 一种建立鸡永生化前脂肪细胞的方法
CN103695466B (zh) * 2013-12-17 2016-04-27 中国农业大学 一种诱导动物体外细胞可逆永生化的载体及其应用
EP3387113A1 (en) * 2015-12-11 2018-10-17 Intervet International B.V. Immortalised chicken embryonic epithelial kidney cells

Also Published As

Publication number Publication date
CN107002044B (zh) 2020-10-30
EP3227433A1 (en) 2017-10-11
EP3227433B1 (en) 2018-10-10
US20180171309A1 (en) 2018-06-21
BR112017011582A2 (pt) 2018-02-27
RU2017119011A3 (es) 2019-01-09
RU2017119011A (ru) 2019-01-09
PL3227433T3 (pl) 2019-01-31
WO2016087560A1 (en) 2016-06-09
US10428316B2 (en) 2019-10-01
JP2017537624A (ja) 2017-12-21
ES2700147T3 (es) 2019-02-14
RU2694318C2 (ru) 2019-07-11
JP6546659B2 (ja) 2019-07-17
CN107002044A (zh) 2017-08-01

Similar Documents

Publication Publication Date Title
MX2017007196A (es) Fibroblastos de embrion de pollo inmortalizados.
HK1246180A1 (zh) 使用自然殺傷細胞治療血液病症、實體瘤或感染性疾病的方法
ZA201608303B (en) Methods for harvesting mammalian cell cultures
BR112018002600A2 (pt) células para imunoterapia modificadas para direcionamento ao antígeno cd38 e para inativação do gene cd38
MX2017006127A (es) Metodos y composiciones para produccion de proteina de clara de huevo.
IL249828A0 (en) Limbal stem cells of cultured mammals, methods of their creation and uses thereof
MX2020000621A (es) Composiciones para usarse en inmunomodulacion.
BR112016017806A2 (pt) células para imunoterapia engenheiradas para direcionamento de antígeno presente em ambas as células imunes e células patológicas
EP3347473A4 (en) METHODS FOR COMBINING ADOPTIVE TRANSFER THERAPY OF T-CELLS WITH ONCOLYTIC VIRUS ADHERENCE THERAPY
MY181175A (en) Therapeutic hpv16 vaccines
EP3224349A4 (en) Method for culturing natural killer cells using t cells
MY192824A (en) Compound targeting il-23a and tnf-alpha and uses thereof
EP3380616A4 (en) MANUFACTURE OF VIRUSES IN BIRDS
MY191539A (en) Streptococcal vaccine
EP3489351A4 (en) CELL CULTIVATION METHOD, SUSPENDED CELL ELIMINATION METHOD AND METHOD FOR KILLING SUSPENDED CELLS
EP3380611A4 (en) PRODUCTION OF VIRUSES IN A CELL CULTURE
IL251616B (en) Methods and compounds for the treatment and prevention of muscle mass loss
IN2014MU00455A (es)
MA39990A (fr) Induction de régénération cardiaque par micro-arn
ITUB20151992A1 (it) Piastra multi-pozzetto per colture cellulari
MX2015016765A (es) Celulas aviares para la produccion mejorada de virus.
MX2016012085A (es) Metodos para producir glucoproteinas recombinantes con glucosilacion modificada.
EP3183333A4 (en) Primary mammalian cell culture systems and methods
EA201691203A1 (ru) Твёрдые формы тенофовира
IN2014DE01009A (es)

Legal Events

Date Code Title Description
FG Grant or registration